Novartis India Ltd - 500672 - Newspaper Advertisement Regarding Transfer Of Shares Of Novartis India Limited To Investor Education And Protection Fund Suspense Account
Apropos the subject matter quoted above, please find enclosed herewith the copies of the newspaper Notices in 'Financial Express' and 'Navshakti' on July 21, 2021.
Novartis set to deliver 50 mn CureVac COVID-19 vaccines this year
"We have started the production as planned. We are planning to deliver 50 million doses this year," Kirsch said of the CureVac deal when asked whether it could instead make its capacity free for others after CureVac said last month its COVID-19 jab was only 48% effective. Novartis India Ltd - 500672 - Shareholding for the Period Ended June 30, 2021
Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here NOVARTIS INDIA LTD. - 500672 - Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2021
Apropos the subject matter quoted above, please find enclosed herewith the disclosure of Related Party Transactions on a standalone basis, in format as specified in the relevant accounting standards for the half year ended March 31, 2021. The above is for your information and the same is also available on the Company''s website i.e. www.novartis.in Novartis India Ltd - 500672 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In reference to the above captioned subject, the certificate dated July 5, 2021, issued by the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited, in terms of the provisions of the said Regulations, for the quarter ended June 30, 2021, is enclosed herewith for your records. Novartis India Ltd - 500672 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Trivikram GudaDesignation :- Company Secretary and Compliance Officer NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Apropos the subject matter quoted above, please find enclosed herewith the copies of the newspaper Notices in 'Financial Express' and 'Navshakti' on July 1, 2021. This is for your information and record. Thanking you. Novartis India Ltd - 500672 - Board Meeting Intimation for For Considering The Unaudited Financials Results For June Quarter.
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve the Unaudited financial results of the Company for the first quarter ending on June 30, 2021 ("said results"). Novartis India Ltd - 500672 - Closure of Trading Window
Please be informed that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 11, 2021, to inter alia consider the Unaudited financial results of the Company for the first quarter ending on June 30, 2021 ("said results"). In this connection, further note that pursuant to the Company''s Code of Conduct to regulate, monitor and report share trading by Insiders ["the Code"], the trading window for dealing in securities of the Company shall remain closed from Thursday, July 1, 2021 to Friday, August 13, 2021 (both days inclusive). The same is being duly communicated to all the Designated Persons under the Code which is available on the Company''s website i.e. www.novartis.in. This is for your information. Thanking You. NOVARTIS INDIA LTD. - 500672 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Annual Secretarial Compliance Report of the Company issued by Mr. K. G. Saraf, Practicing Company Secretary for the financial year 2020-21. You are requested to kindly take the above information on record.